Seres Therapeutics (MCRB) Market Capitalization (2015 - 2026)

Seres Therapeutics has disclosed Market Capitalization across 12 years of filings, most recently posting $77.5 million for Q2 2026.

• In Q2 2026, Market Capitalization fell 20.28% year-over-year to $77.5 million; the TTM figure through Jun 2026 stood at $77.5 million (down 20.28% YoY), while the FY2025 annual figure was $142.2 million, down 1.09% from the prior year.
• Market Capitalization came in at $77.5 million for Q2 2026 at Seres Therapeutics, down from $85.1 million in the prior quarter.
• In the past five years, Market Capitalization ranged from a high of $798.7 million in Q3 2022 to a low of $77.5 million in Q2 2026.
• Average Market Capitalization over 5 years is $306.9 million, with a median of $164.8 million recorded in 2024.
• Year-over-year, Market Capitalization tumbled 85.53% in 2022 and soared 93.71% in 2023.
• Over 5 years, Market Capitalization stood at $701.2 million in 2022, then plunged by 73.04% to $189.1 million in 2023, then fell by 23.95% to $143.8 million in 2024, then retreated by 1.09% to $142.2 million in 2025, then tumbled by 45.47% to $77.5 million in 2026.
• Per Business Quant data, the three most recent Market Capitalization figures were $77.5 million in Q2 2026, $85.1 million in Q1 2026, and $142.2 million in Q4 2025.